1. Home
  2. PRAX vs NRDS Comparison

PRAX vs NRDS Comparison

Compare PRAX & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$299.33

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo NerdWallet Inc.

NRDS

NerdWallet Inc.

HOLD

Current Price

$9.04

Market Cap

631.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
NRDS
Founded
2015
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
631.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PRAX
NRDS
Price
$299.33
$9.04
Analyst Decision
Strong Buy
Buy
Analyst Count
15
5
Target Price
$572.13
$15.00
AVG Volume (30 Days)
296.5K
574.3K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.42
EPS
N/A
0.37
Revenue
N/A
$836,600,000.00
Revenue This Year
N/A
$10.13
Revenue Next Year
$7,758.26
$7.11
P/E Ratio
N/A
$24.92
Revenue Growth
N/A
21.67
52 Week Low
$41.78
$7.33
52 Week High
$392.70
$16.24

Technical Indicators

Market Signals
Indicator
PRAX
NRDS
Relative Strength Index (RSI) 30.44 38.64
Support Level $290.53 $9.07
Resistance Level $328.24 $9.75
Average True Range (ATR) 14.50 0.25
MACD -6.89 -0.08
Stochastic Oscillator 5.68 8.78

Price Performance

Historical Comparison
PRAX
NRDS

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. The Company's platform comprises three primary components: Editorial and Content Publishing, Marketplace and Referral Services, and Financial Services. It operates in the United States, Canada, and the United Kingdom.

Share on Social Networks: